Trexquant Investment’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Trexquant Investment’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,481	Closed	-$209K	–	1469
2017 Q4	$209K	Buy	+2,481	New	+$243K	0.02%	918
2017 Q2	–	Sell	-1,708	Closed	-$211K	–	1271
2017 Q1	$211K	Buy	+1,708	New	+$224K	0.03%	941
2016 Q2	–	Sell	-1,574	Closed	-$147K	–	1171
2016 Q1	$147K	Sell	1,574 -961	-38%	-$105K	0.02%	858
2015 Q4	$514K	Buy	+2,535	New	+$453K	0.05%	669

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trexquant Investment's BLCM Position: Q1 2018 in Review

Trexquant Investment sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2018, closing a stake of 2,481 shares — an estimated $209K sold.

Trexquant Investment first reported a position in BLCM in Q4 2015 and held it in 4 quarters. The position peaked at $514K in Q4 2015. 90 funds tracked by Wall St. Rank hold BLCM as of Q1 2018.

Trexquant Investment reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Trexquant Investment sold 2,481 Bellicum Pharmaceuticals, Inc. shares in Q1 2018, an estimated $209K.
Trexquant Investment first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2015 and held it in 4 quarters.
Trexquant Investment's Bellicum Pharmaceuticals, Inc. position peaked at $514K in Q4 2015.
90 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2018.

Based on Trexquant Investment's 13F filing for Q1 2018, filed 3 May 2018.